egtazic acid has been researched along with picibanil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, M; Kato, H; Kondo, M; Sano, H; Sugino, S; Tanigawa, M; Yamamura, Y | 1 |
| Fujimura, T; Torisu, M | 1 |
2 other study(ies) available for egtazic acid and picibanil
| Article | Year |
|---|---|
Mechanism of polymorphonuclear leukocytes accumulation examined using inhibitors of complement and arachidonic acid cascade in rats treated with OK-432.
Topics: Animals; Arachidonic Acids; Benzamidines; Benzoquinones; Biological Products; Cell Count; Chemotactic Factors; Complement C5a; Complement Inactivator Proteins; Edetic Acid; Egtazic Acid; Guanidines; Humans; Male; Methacrylates; Neutrophils; Peritoneal Cavity; Picibanil; Quinones; Rats; Rats, Inbred Strains; Sesquiterpenes | 1989 |
Neutrophil-mediated tumor cell destruction in cancer ascites. II. A OK-432 attracts killer neutrophils through activation of complement C5.
Topics: Adult; Aged; Ascites; Biological Products; Chemotaxis, Leukocyte; Complement Activation; Complement C5; Cytotoxicity, Immunologic; Edetic Acid; Egtazic Acid; Hot Temperature; Humans; Middle Aged; Neutrophils; Picibanil | 1987 |